| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $5.1B | $13.6B | $14.7B | $14.5B | $12.9B | $3.1B | $2.6B |
| Cost of Revenue | $12.2B | $10.9B | $12.0B | $11.7B | $10.1B | $9.9B | $7.7B |
| Gross Profit | $0.9B | $2.7B | $2.7B | $2.8B | $2.7B | $0.7B | $0.5B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $1.2B | $1.3B | $1.2B | $1.3B | $1.3B | $1.4B | $1.0B |
| Operating Income | $1.0B | $1.2B | $1.5B | $1.2B | $1.3B | $1.0B | $0.8B |
| Net Income | $-0.0B | $0.7B | $1.0B | $0.8B | $0.9B | $0.2B | $0.1B |
| EPS (Basic) | $-0.02 | $0.51 | $0.71 | $0.53 | $0.60 | $0.11 | $0.06 |
| EPS (Diluted) | $0.32 | $0.51 | $0.70 | $0.53 | $0.60 | $0.11 | $0.06 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $37.1B | $16.5B | $17.0B | $17.4B | $17.2B | $16.4B | $17.2B |
| Current Assets | $8.4B | $5.0B | $5.3B | $5.9B | $5.3B | $4.5B | $5.2B |
| Cash & Equivalents | $0.8B | $0.6B | $0.7B | $0.8B | $0.8B | $0.7B | $0.6B |
| Total Liabilities | $25.3B | $12.6B | $12.9B | $13.3B | $12.4B | $11.8B | $11.5B |
| Current Liabilities | $7.0B | $4.3B | $4.5B | $5.1B | $4.3B | $4.0B | $4.5B |
| Stockholders' Equity | $11.7B | $3.9B | $4.0B | $4.1B | $4.8B | $4.6B | $5.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.3B | $1.3B | $1.5B | $1.5B | $1.4B | $0.8B |
| Investing Cash Flow | $-2.1B | $-0.5B | $-0.3B | $-0.5B | $-0.2B | $0.0B | $0.0B |
| Capital Expenditures | — | — | — | — | — | — | $0.3B |
| Financing Cash Flow | $0.9B | $-0.9B | $-1.0B | $-0.9B | $-1.2B | $-1.2B | $-0.8B |